Avanos Medical (AVNS)
(Delayed Data from NYSE)
$10.98 USD
-0.19 (-1.70%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $10.99 +0.01 (0.09%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth B Momentum A VGM
Fundamental Charts
About Market Cap
As of the previous market close, AVANOS MEDICAL, INC. has a market cap of $516.54M, which represents its share price of $11.17 multiplied by its outstanding shares number of 46.24M. As a small-cap company, AVNS's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
AVNS 10.98 -0.19(-1.70%)
Will AVNS be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for AVNS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AVNS
New Strong Sell Stocks for July 15th
Avanos Medical (AVNS) International Revenue in Focus: Trends and Expectations
AVNS: What are Zacks experts saying now?
Zacks Private Portfolio Services
New Strong Sell Stocks for May 9th
AVNS Stock Gains Post Q1 Earnings & Revenue Beat, Gross Margin Down
Avanos Medical (AVNS) Q1 Earnings and Revenues Top Estimates
Other News for AVNS
Avanos Announces Divestiture of Hyaluronic Acid Product Line to Channel-Markers Medical | AVNS ...
Avanos announces divestiture of Hyaluronic Acid product line to Channel-Markers Medical
Avanos divests Hyaluronic Acid product line to Channel-Markers Medical
Avanos Medical, Inc. to Webcast Conference Call Discussing Second Quarter 2025 Financial ...
Avanos (AVNS) Welcomes New Chief Human Resources Officer | AVNS Stock News